AlTi Global’s Genenta Science SAEN Stock Holding History

AlTi Global’s Portfolio SAEN Stock Details SAEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200,288	Closed	-$135K	–	511
2026 Q1	$135K	Hold	200,288	–	–	﹤0.01%	431
2025 Q4	$298K	Hold	200,288	–	–	0.01%	377
2025 Q3	$637K	Hold	200,288	–	–	0.01%	292
2025 Q2	$791K	Hold	200,288	–	–	0.02%	260
2025 Q1	$795K	Hold	200,288	–	–	0.02%	232
2024 Q4	$753K	Hold	200,288	–	–	0.02%	243
2024 Q3	$855K	Hold	200,288	–	–	0.02%	228
2024 Q2	$621K	Buy	+200,288	New	+$660K	0.02%	239

Other funds holding SAEN

Eurizon Capital SGR SpA Milan $37.6B AUM 38.21% 1-Year Est. Return

Allianz Munich, Germany $9.49B AUM 23.65% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $3.43B AUM 16.22% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AlTi Global's SAEN Position: Q2 2026 in Review

AlTi Global sold out of Genenta Science (SAEN) in Q2 2026, closing a stake of 200,288 shares — an estimated $135K sold.

AlTi Global first reported a position in SAEN in Q2 2024 and held it in 8 quarters. The position peaked at $855K in Q3 2024. 9 funds tracked by Wall St. Rank hold SAEN as of Q2 2026.

AlTi Global reported no remaining Genenta Science position as of Q2 2026 after selling out during the quarter.
AlTi Global sold 200,288 Genenta Science shares in Q2 2026, an estimated $135K.
AlTi Global first reported a position in Genenta Science in Q2 2024 and held it in 8 quarters.
AlTi Global's Genenta Science position peaked at $855K in Q3 2024.
9 funds tracked by Wall St. Rank held Genenta Science as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.